Clinical Trial Update: LETHE-AT: a Personalized Multidomain Lifestyle Intervention for Individuals at Increased Risk of Memory Impairment. [NA]

View source ↗

Summary

A clinical trial (LETHE-AT) is evaluating a personalized multidomain lifestyle intervention to reduce memory impairment risk in individuals with mild cognitive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Subjective Cognitive Decline

Snippet

Sponsor: Medical University of Vienna | Conditions: Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD) | NA | Status: NOT_YET_RECRUITING